 | • レポートコード：MRC2Q12-16804 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、ナノベース薬デリバリーシステムの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にナノベース薬デリバリーシステムのグローバル市場のxxx％を占める「50nm以下」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「親水性薬剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 ナノベース薬デリバリーシステムの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのナノベース薬デリバリーシステム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ナノベース薬デリバリーシステムのグローバル主要プレイヤーには、Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ナノベース薬デリバリーシステム市場は、種類と用途によって区分されます。世界のナノベース薬デリバリーシステム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 50nm以下、50-150nm、150-300nm、その他 【用途別セグメント】 親水性薬剤、疎水性薬剤 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ナノベース薬デリバリーシステム製品概要 - 種類別市場（50nm以下、50-150nm、150-300nm、その他） - 用途別市場（親水性薬剤、疎水性薬剤） - 調査の目的 ・エグゼクティブサマリー - 世界のナノベース薬デリバリーシステム販売量予測2017-2028 - 世界のナノベース薬デリバリーシステム売上予測2017-2028 - ナノベース薬デリバリーシステムの地域別販売量 - ナノベース薬デリバリーシステムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ナノベース薬デリバリーシステム販売量 - 主要メーカー別ナノベース薬デリバリーシステム売上 - 主要メーカー別ナノベース薬デリバリーシステム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（50nm以下、50-150nm、150-300nm、その他） - ナノベース薬デリバリーシステムの種類別販売量 - ナノベース薬デリバリーシステムの種類別売上 - ナノベース薬デリバリーシステムの種類別価格 ・用途別市場規模（親水性薬剤、疎水性薬剤） - ナノベース薬デリバリーシステムの用途別販売量 - ナノベース薬デリバリーシステムの用途別売上 - ナノベース薬デリバリーシステムの用途別価格 ・北米市場 - 北米のナノベース薬デリバリーシステム市場規模（種類別、用途別） - 主要国別のナノベース薬デリバリーシステム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのナノベース薬デリバリーシステム市場規模（種類別、用途別） - 主要国別のナノベース薬デリバリーシステム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のナノベース薬デリバリーシステム市場規模（種類別、用途別） - 主要国別のナノベース薬デリバリーシステム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のナノベース薬デリバリーシステム市場規模（種類別、用途別） - 主要国別のナノベース薬デリバリーシステム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのナノベース薬デリバリーシステム市場規模（種類別、用途別） - 主要国別のナノベース薬デリバリーシステム市場規模（トルコ、サウジアラビア） ・企業情報 Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticals ・産業チェーン及び販売チャネル分析 - ナノベース薬デリバリーシステムの産業チェーン分析 - ナノベース薬デリバリーシステムの原材料 - ナノベース薬デリバリーシステムの生産プロセス - ナノベース薬デリバリーシステムの販売及びマーケティング - ナノベース薬デリバリーシステムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ナノベース薬デリバリーシステムの産業動向 - ナノベース薬デリバリーシステムのマーケットドライバー - ナノベース薬デリバリーシステムの課題 - ナノベース薬デリバリーシステムの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Nano-based Drug Delivery System estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Nano-based Drug Delivery System include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Nano-based Drug Delivery System companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Nano-based Drug Delivery System market. Further, it explains the major drivers and regional dynamics of the global Nano-based Drug Delivery System market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Nano-based Drug Delivery System Segment by Type
Less than 50nm
50-150nm
150-300nm
Others
Nano-based Drug Delivery System Segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nano-based Drug Delivery System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Nano-based Drug Delivery System market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Nano-based Drug Delivery System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nano-based Drug Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nano-based Drug Delivery System revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Nano-based Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Nano-based Drug Delivery System revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Nano-based Drug Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nano-based Drug Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nano-based Drug Delivery System revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano-based Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Less than 50nm
1.2.3 50-150nm
1.2.4 150-300nm
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nano-based Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nano-based Drug Delivery System Market Perspective (2017-2028)
2.2 Nano-based Drug Delivery System Growth Trends by Region
2.2.1 Nano-based Drug Delivery System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nano-based Drug Delivery System Historic Market Size by Region (2017-2022)
2.2.3 Nano-based Drug Delivery System Forecasted Market Size by Region (2023-2028)
2.3 Nano-based Drug Delivery System Market Dynamics
2.3.1 Nano-based Drug Delivery System Industry Trends
2.3.2 Nano-based Drug Delivery System Market Drivers
2.3.3 Nano-based Drug Delivery System Market Challenges
2.3.4 Nano-based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano-based Drug Delivery System Players by Revenue
3.1.1 Global Top Nano-based Drug Delivery System Players by Revenue (2017-2022)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2017-2022)
3.2 Global Nano-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nano-based Drug Delivery System Revenue
3.4 Global Nano-based Drug Delivery System Market Concentration Ratio
3.4.1 Global Nano-based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano-based Drug Delivery System Revenue in 2021
3.5 Nano-based Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Nano-based Drug Delivery System Product Solution and Service
3.7 Date of Enter into Nano-based Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano-based Drug Delivery System Breakdown Data by Type
4.1 Global Nano-based Drug Delivery System Historic Market Size by Type (2017-2022)
4.2 Global Nano-based Drug Delivery System Forecasted Market Size by Type (2023-2028)
5 Nano-based Drug Delivery System Breakdown Data by Application
5.1 Global Nano-based Drug Delivery System Historic Market Size by Application (2017-2022)
5.2 Global Nano-based Drug Delivery System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nano-based Drug Delivery System Market Size (2017-2028)
6.2 North America Nano-based Drug Delivery System Market Size by Type
6.2.1 North America Nano-based Drug Delivery System Market Size by Type (2017-2022)
6.2.2 North America Nano-based Drug Delivery System Market Size by Type (2023-2028)
6.2.3 North America Nano-based Drug Delivery System Market Share by Type (2017-2028)
6.3 North America Nano-based Drug Delivery System Market Size by Application
6.3.1 North America Nano-based Drug Delivery System Market Size by Application (2017-2022)
6.3.2 North America Nano-based Drug Delivery System Market Size by Application (2023-2028)
6.3.3 North America Nano-based Drug Delivery System Market Share by Application (2017-2028)
6.4 North America Nano-based Drug Delivery System Market Size by Country
6.4.1 North America Nano-based Drug Delivery System Market Size by Country (2017-2022)
6.4.2 North America Nano-based Drug Delivery System Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nano-based Drug Delivery System Market Size (2017-2028)
7.2 Europe Nano-based Drug Delivery System Market Size by Type
7.2.1 Europe Nano-based Drug Delivery System Market Size by Type (2017-2022)
7.2.2 Europe Nano-based Drug Delivery System Market Size by Type (2023-2028)
7.2.3 Europe Nano-based Drug Delivery System Market Share by Type (2017-2028)
7.3 Europe Nano-based Drug Delivery System Market Size by Application
7.3.1 Europe Nano-based Drug Delivery System Market Size by Application (2017-2022)
7.3.2 Europe Nano-based Drug Delivery System Market Size by Application (2023-2028)
7.3.3 Europe Nano-based Drug Delivery System Market Share by Application (2017-2028)
7.4 Europe Nano-based Drug Delivery System Market Size by Country
7.4.1 Europe Nano-based Drug Delivery System Market Size by Country (2017-2022)
7.4.2 Europe Nano-based Drug Delivery System Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano-based Drug Delivery System Market Size (2017-2028)
8.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Type
8.2.1 Asia-Pacific Nano-based Drug Delivery System Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nano-based Drug Delivery System Market Share by Type (2017-2028)
8.3 Asia-Pacific Nano-based Drug Delivery System Market Size by Application
8.3.1 Asia-Pacific Nano-based Drug Delivery System Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nano-based Drug Delivery System Market Share by Application (2017-2028)
8.4 Asia-Pacific Nano-based Drug Delivery System Market Size by Region
8.4.1 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nano-based Drug Delivery System Market Size (2017-2028)
9.2 Latin America Nano-based Drug Delivery System Market Size by Type
9.2.1 Latin America Nano-based Drug Delivery System Market Size by Type (2017-2022)
9.2.2 Latin America Nano-based Drug Delivery System Market Size by Type (2023-2028)
9.2.3 Latin America Nano-based Drug Delivery System Market Share by Type (2017-2028)
9.3 Latin America Nano-based Drug Delivery System Market Size by Application
9.3.1 Latin America Nano-based Drug Delivery System Market Size by Application (2017-2022)
9.3.2 Latin America Nano-based Drug Delivery System Market Size by Application (2023-2028)
9.3.3 Latin America Nano-based Drug Delivery System Market Share by Application (2017-2028)
9.4 Latin America Nano-based Drug Delivery System Market Size by Country
9.4.1 Latin America Nano-based Drug Delivery System Market Size by Country (2017-2022)
9.4.2 Latin America Nano-based Drug Delivery System Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano-based Drug Delivery System Market Size (2017-2028)
10.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type
10.2.1 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nano-based Drug Delivery System Market Share by Type (2017-2028)
10.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Application
10.3.1 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nano-based Drug Delivery System Market Share by Application (2017-2028)
10.4 Middle East & Africa Nano-based Drug Delivery System Market Size by Country
10.4.1 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Nano-based Drug Delivery System Introduction
11.1.4 Amgen Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.1.5 Amgen Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Nano-based Drug Delivery System Introduction
11.2.4 Teva Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Nano-based Drug Delivery System Introduction
11.3.4 Roche Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Details
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.4.5 UCB (Union Chimique Belge) Recent Developments
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Nano-based Drug Delivery System Introduction
11.5.4 Celgene Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.5.5 Celgene Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Nano-based Drug Delivery System Introduction
11.6.4 Merck Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Nano-based Drug Delivery System Introduction
11.7.4 Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.7.5 Gilead Sciences Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nano-based Drug Delivery System Introduction
11.8.4 Sanofi Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nano-based Drug Delivery System Introduction
11.9.4 Pfizer Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.9.5 Pfizer Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Nano-based Drug Delivery System Introduction
11.10.4 Takeda Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.10.5 Takeda Recent Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Details
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Introduction
11.11.4 Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.11.5 Bausch&Lomb Recent Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Details
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.12.5 Samyang Biopharmaceuticals Recent Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Introduction
11.13.4 Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.13.5 Johnson & Johnson Recent Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Details
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Nano-based Drug Delivery System Introduction
11.14.4 TOLMAR Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.14.5 TOLMAR Recent Developments
11.15 Astellas
11.15.1 Astellas Company Details
11.15.2 Astellas Business Overview
11.15.3 Astellas Nano-based Drug Delivery System Introduction
11.15.4 Astellas Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.15.5 Astellas Recent Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Details
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.16.5 AMAG Pharmaceuticals Recent Developments
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Nano-based Drug Delivery System Introduction
11.17.4 AbbVie Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.17.5 AbbVie Recent Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Details
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Nano-based Drug Delivery System Introduction
11.18.4 Dr Reddy Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.18.5 Dr Reddy Recent Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Details
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Nano-based Drug Delivery System Introduction
11.19.4 AstraZeneca Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.19.5 AstraZeneca Recent Developments
11.20 Aspen
11.20.1 Aspen Company Details
11.20.2 Aspen Business Overview
11.20.3 Aspen Nano-based Drug Delivery System Introduction
11.20.4 Aspen Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.20.5 Aspen Recent Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Details
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Introduction
11.21.4 Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.21.5 Acrotech Biopharma Recent Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Details
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Introduction
11.22.4 TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.22.5 TWi Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Nano-based Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Less than 50nm
Table 3. Key Players of 50-150nm
Table 4. Key Players of 150-300nm
Table 5. Key Players of Others
Table 6. Global Nano-based Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Nano-based Drug Delivery System Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nano-based Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Nano-based Drug Delivery System Market Share by Region (2017-2022)
Table 10. Global Nano-based Drug Delivery System Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Nano-based Drug Delivery System Market Share by Region (2023-2028)
Table 12. Nano-based Drug Delivery System Market Trends
Table 13. Nano-based Drug Delivery System Market Drivers
Table 14. Nano-based Drug Delivery System Market Challenges
Table 15. Nano-based Drug Delivery System Market Restraints
Table 16. Global Nano-based Drug Delivery System Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Nano-based Drug Delivery System Revenue Share by Players (2017-2022)
Table 18. Global Top Nano-based Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-based Drug Delivery System as of 2021)
Table 19. Ranking of Global Top Nano-based Drug Delivery System Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Nano-based Drug Delivery System Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nano-based Drug Delivery System Product Solution and Service
Table 23. Date of Enter into Nano-based Drug Delivery System Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nano-based Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Nano-based Drug Delivery System Revenue Market Share by Type (2017-2022)
Table 27. Global Nano-based Drug Delivery System Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Nano-based Drug Delivery System Revenue Market Share by Type (2023-2028)
Table 29. Global Nano-based Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Nano-based Drug Delivery System Revenue Share by Application (2017-2022)
Table 31. Global Nano-based Drug Delivery System Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Nano-based Drug Delivery System Revenue Share by Application (2023-2028)
Table 33. North America Nano-based Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Nano-based Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Nano-based Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Nano-based Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Nano-based Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Nano-based Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Nano-based Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Nano-based Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Nano-based Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Nano-based Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Nano-based Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Nano-based Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Nano-based Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Nano-based Drug Delivery System Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Nano-based Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Nano-based Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Nano-based Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Nano-based Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Nano-based Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Nano-based Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Nano-based Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Nano-based Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Nano-based Drug Delivery System Product
Table 66. Amgen Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 67. Amgen Recent Developments
Table 68. Teva Company Details
Table 69. Teva Business Overview
Table 70. Teva Nano-based Drug Delivery System Product
Table 71. Teva Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 72. Teva Recent Developments
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Nano-based Drug Delivery System Product
Table 76. Roche Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 77. Roche Recent Developments
Table 78. UCB (Union Chimique Belge) Company Details
Table 79. UCB (Union Chimique Belge) Business Overview
Table 80. UCB (Union Chimique Belge) Nano-based Drug Delivery System Product
Table 81. UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 82. UCB (Union Chimique Belge) Recent Developments
Table 83. Celgene Company Details
Table 84. Celgene Business Overview
Table 85. Celgene Nano-based Drug Delivery System Product
Table 86. Celgene Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 87. Celgene Recent Developments
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Nano-based Drug Delivery System Product
Table 91. Merck Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 92. Merck Recent Developments
Table 93. Gilead Sciences Company Details
Table 94. Gilead Sciences Business Overview
Table 95. Gilead Sciences Nano-based Drug Delivery System Product
Table 96. Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 97. Gilead Sciences Recent Developments
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Nano-based Drug Delivery System Product
Table 101. Sanofi Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 102. Sanofi Recent Developments
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Nano-based Drug Delivery System Product
Table 106. Pfizer Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 107. Pfizer Recent Developments
Table 108. Takeda Company Details
Table 109. Takeda Business Overview
Table 110. Takeda Nano-based Drug Delivery System Product
Table 111. Takeda Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 112. Takeda Recent Developments
Table 113. Bausch&Lomb Company Details
Table 114. Bausch&Lomb Business Overview
Table 115. Bausch&Lomb Nano-based Drug Delivery System Product
Table 116. Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 117. Bausch&Lomb Recent Developments
Table 118. Samyang Biopharmaceuticals Company Details
Table 119. Samyang Biopharmaceuticals Business Overview
Table 120. Samyang Biopharmaceuticals Nano-based Drug Delivery System Product
Table 121. Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 122. Samyang Biopharmaceuticals Recent Developments
Table 123. Johnson & Johnson Company Details
Table 124. Johnson & Johnson Business Overview
Table 125. Johnson & Johnson Nano-based Drug Delivery System Product
Table 126. Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 127. Johnson & Johnson Recent Developments
Table 128. TOLMAR Company Details
Table 129. TOLMAR Business Overview
Table 130. TOLMAR Nano-based Drug Delivery System Product
Table 131. TOLMAR Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 132. TOLMAR Recent Developments
Table 133. Astellas Company Details
Table 134. Astellas Business Overview
Table 135. Astellas Nano-based Drug Delivery System Product
Table 136. Astellas Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 137. Astellas Recent Developments
Table 138. AMAG Pharmaceuticals Company Details
Table 139. AMAG Pharmaceuticals Business Overview
Table 140. AMAG Pharmaceuticals Nano-based Drug Delivery System Product
Table 141. AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 142. AMAG Pharmaceuticals Recent Developments
Table 143. AbbVie Company Details
Table 144. AbbVie Business Overview
Table 145. AbbVie Nano-based Drug Delivery System Product
Table 146. AbbVie Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 147. AbbVie Recent Developments
Table 148. Dr Reddy Company Details
Table 149. Dr Reddy Business Overview
Table 150. Dr Reddy Nano-based Drug Delivery System Product
Table 151. Dr Reddy Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 152. Dr Reddy Recent Developments
Table 153. AstraZeneca Company Details
Table 154. AstraZeneca Business Overview
Table 155. AstraZeneca Nano-based Drug Delivery System Product
Table 156. AstraZeneca Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 157. AstraZeneca Recent Developments
Table 158. Aspen Company Details
Table 159. Aspen Business Overview
Table 160. Aspen Nano-based Drug Delivery System Product
Table 161. Aspen Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 162. Aspen Recent Developments
Table 163. Acrotech Biopharma Company Details
Table 164. Acrotech Biopharma Business Overview
Table 165. Acrotech Biopharma Nano-based Drug Delivery System Product
Table 166. Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 167. Acrotech Biopharma Recent Developments
Table 168. TWi Pharmaceuticals Company Details
Table 169. TWi Pharmaceuticals Business Overview
Table 170. TWi Pharmaceuticals Nano-based Drug Delivery System Product
Table 171. TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 172. TWi Pharmaceuticals Recent Developments
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nano-based Drug Delivery System Market Share by Type: 2021 VS 2028
Figure 2. Less than 50nm Features
Figure 3. 50-150nm Features
Figure 4. 150-300nm Features
Figure 5. Others Features
Figure 6. Global Nano-based Drug Delivery System Market Share by Application: 2021 VS 2028
Figure 7. Hydrophilic Drugs Case Studies
Figure 8. Hydrophobic Drugs Case Studies
Figure 9. Nano-based Drug Delivery System Report Years Considered
Figure 10. Global Nano-based Drug Delivery System Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Nano-based Drug Delivery System Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Nano-based Drug Delivery System Market Share by Region: 2021 VS 2028
Figure 13. Global Nano-based Drug Delivery System Market Share by Players in 2021
Figure 14. Global Top Nano-based Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-based Drug Delivery System as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Nano-based Drug Delivery System Revenue in 2021
Figure 16. North America Nano-based Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Nano-based Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 18. North America Nano-based Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 19. North America Nano-based Drug Delivery System Market Size Share by Country (2017-2028)
Figure 20. United States Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Nano-based Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Nano-based Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 24. Europe Nano-based Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 25. Europe Nano-based Drug Delivery System Market Size Share by Country (2017-2028)
Figure 26. Germany Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Nano-based Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Nano-based Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Nano-based Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Nano-based Drug Delivery System Market Size Share by Region (2017-2028)
Figure 36. China Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Nano-based Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Nano-based Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Nano-based Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Nano-based Drug Delivery System Market Size Share by Country (2017-2028)
Figure 46. Mexico Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Nano-based Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Nano-based Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Nano-based Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Nano-based Drug Delivery System Market Size Share by Country (2017-2028)
Figure 52. Turkey Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Amgen Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 56. Teva Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 57. Roche Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 58. UCB (Union Chimique Belge) Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 59. Celgene Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 61. Gilead Sciences Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 62. Sanofi Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 63. Pfizer Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 64. Takeda Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 65. Bausch&Lomb Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 66. Samyang Biopharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 67. Johnson & Johnson Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 68. TOLMAR Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 69. Astellas Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 70. AMAG Pharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 71. AbbVie Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 72. Dr Reddy Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 73. AstraZeneca Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 74. Aspen Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 75. Acrotech Biopharma Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 76. TWi Pharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed